As shown in Fig 3, osteopontin (encoded by SPP1) and CXCL10 are both increased in the plasma of subjects with NAFLD, regardless of severity, including those with NAS 0–1. The gene discussed is SPP1; the disease is metabolic dysfunction-associated steatotic liver disease.